Emma Rey Jurado
Professor/Researcher
Universidad del Desarrollo
Santiago, Chile
- Primary immunodeficiencies - Susceptibility to infections - Immunopathogenesis of respiratory viruses; - Host-pathogen interactions - Efficiency of drug-combinations against M. tuberculosis
-
Biología. Especialidad Microbiología, UNIVERSIDAD AUTONOMA DE BARCELONA. España, 2007
-
Doctor en Biología, UNIVERSIDAD DE BARCELONA. España, 2013
-
Postdoctorante Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Chile
2014 - 2018
-
Profesora Part Time
Universidad Santo Tomás
Chile
2019 - 2020
-
Professor/Researcher Full Time
Universidad del Desarrollo
Chile
2020 - At present
-
Estudiante predoctoral
Hospital Clínico de Barcelona. Universidad de Barcelona
España
2008 - 2013
-
Visitante predoctoral
National Institute for Medical Research
Reino Unido
2011 - 2011
-
Investigador postdoctoral
Public Health Research Institute
Estados Unidos
2013 - 2014
-
Postdoctorante Full Time
Pontificia Universidad Católica de Chile
Santiago, Chile
2014 - 2018
-
Profesora Part Time
Universidad Santo Tomás
Santiago, Chile
2019 - At present
-
Profesora/Postdoctorante Full Time
Universidad del Desarrollo
Chile
2020 - At present
I have mentored graduated and PhD students to obtain their degrees:
Álex López-Galvín, Master student at University of Barcelona.
Derek Ray, graduate student at Rutgers University.
Andrés Mansilla, PhD student at Pontificia Universidad Católica de Chile.
Nicolás Gálvez, PhD student at Pontificia Universidad Católica de Chile.
I have presented our results at scientific meetings at national and international annual meetings including Federation of Clinical Immunology Societies (FOCIS) meetings, Congress of the Latin American Society of Immunology (ALAI) and Sociedad de Microbiología de Chile (SOMICH), Sociedad Española de Microbiología (SEIMC) and ESCMID. These events brought together national and international investigators, thus promoting collaborations in the field of immunology and translational biomedicine.
I were present in El Mostrador national newspaper on 4th November of 2015, contributing to better knowledge about Tuberculosis as well as the project granted by CONICYT. At such occasion, we were accessible to a significant number of people in Chile.
-
Pumarola Award
Societat Catalana de Malalties Infeccioses i Microbiologia Clínica i de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC)
España, 2008
Award “Agustí Pumarola” by the “ Societat Catalana de Malalties Infeccioses i Microbiología Clínica i de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC)” to develop a project entitled “Study of the infective capacity over macrophages of drug-resistant Mycobacterium tuberculosis and evaluation of the synergic activity of different drug combinations.
-
LASID fellowship award
Latin American Society for Immunodeficiencies
México, 2020
The Latin American Society of Primary Immunodeficiency LASID is an association of professionals dedicated to develop and perfect education, scientific research and health care within the field of Inborn Errors of Immunity (IEI). Scholarship Program Fellowship Award, which offers an award to an individual for training during two years in the field of primary immunodeficiency diseases.
Clinical trial of safety, tolerability and immunogenicity of a recombinant vaccine against respiratory syncytial virus |
CHARACTERIZATION AND FUNCTIONAL RELEVANCE OF THE T CELL RECEPTOR REPERTOIRE OF HRSV-SPECIFIC T CELLS EXPANDED IN RESPONSE TO HRSV INFECTION IN NAIVE AND VACCINATED MICE. |
ELUCIDATING THE MECHANISMS OF PATHOGENICITY USED BY THE HUMAN RESPIRATORY SYNCYTIAL VIRUS TO PREVENT T CELL ACTIVATION AND CAUSE CENTRAL NERVOUS SYSTEM INFLAMMATION. |
Estudio de la actividad sinérgica de combinaciones de fármacos antituberculosos frente a aislados clínicos de M.tuberculosis multirresistentes utilizando un modelo in vitro y un modelo ex-vivo con macrófagos humanos. |
Detección rápida de la resistencia a los fármacos de primera línea en Mycobacterium tuberculosis mediante chips de DNA de baja densidad. Estudio in vitro de la infectividad en macrófagos humanos de los genotipos resistentes más relevantes. |
Eficacia in vitro del tratamiento antibiótico frente a cepas resistentes de Mycobacterium tuberculosis. Estudio de la capacidad infectiva sobre macrófagos y evaluación de la actividad sinérgica de diversas combinaciones de fármacos |